GAMCO Investors’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

GAMCO Investors’s Portfolio TTPH Stock Details TTPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-2,500	Closed	-$24K	–	947
2019 Q2	$24K	Hold	2,500	–	–	﹤0.01%	922
2019 Q1	$67K	Hold	2,500	–	–	﹤0.01%	836
2018 Q4	$57K	Buy	2,500 +750	+43%	+$29.3K	﹤0.01%	789
2018 Q3	$97K	Hold	1,750	–	–	﹤0.01%	821
2018 Q2	$125K	Buy	1,750 +250	+17%	+$17.7K	﹤0.01%	833
2018 Q1	$92K	Buy	+1,500	New	+$132K	﹤0.01%	823

Other funds holding TTPH

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

GAMCO Investors's TTPH Position: Q3 2019 in Review

GAMCO Investors sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q3 2019, closing a stake of 2,500 shares — an estimated $24K sold.

GAMCO Investors first reported a position in TTPH in Q1 2018 and held it in 6 quarters. The position peaked at $125K in Q2 2018. 26 funds tracked by Wall St. Rank hold TTPH as of Q3 2019.

GAMCO Investors reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q3 2019 after selling out during the quarter.
GAMCO Investors sold 2,500 Tetraphase Pharmaceuticals, Inc. shares in Q3 2019, an estimated $24K.
GAMCO Investors first reported a position in Tetraphase Pharmaceuticals, Inc. in Q1 2018 and held it in 6 quarters.
GAMCO Investors's Tetraphase Pharmaceuticals, Inc. position peaked at $125K in Q2 2018.
26 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q3 2019.

Based on GAMCO Investors's 13F filing for Q3 2019, filed 1 Nov 2019.